<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>SPIRIT 2025 Checklist</title>
  <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/css/bootstrap.min.css" rel="stylesheet">
  <style>
    body {
      padding-top: 1rem;
      padding-bottom: 1rem;
    }
    .container {
      max-width: 960px;
    }
  </style>
</head>
<body>
  <div class="container">
    <header class="pb-3 mb-4 border-bottom">
      <div class="d-flex align-items-center justify-content-between">
        <div>
          <h1 class="display-4">SPIRIT 2025 Checklist</h1>
                  </div>
        <div class="btn-group" role="group">
          <button id="importButton" type="button" class="btn btn-outline-primary">Import</button>
          <button id="exportButton" type="button" class="btn btn-primary">Export</button>
        </div>
      </div>
    </header>

    <div class="progress mb-4">
      <div id="progressBar" class="progress-bar" role="progressbar" style="width: 0%;" aria-valuenow="0" aria-valuemin="0" aria-valuemax="100">0%</div>
    </div>

    <main>
      <h1 id="spirit-2025-checklist">SPIRIT 2025 Checklist</h1>
      <blockquote>
      <p>Scope: Standard Protocol Items: Recommendations for
      Interventional Trials.</p>
      <p>Reference: See <code>source/archetypes/spirit-2025.yml</code>
      for canonical link and provenance.</p>
      </blockquote>
      <h2 id="instructions">Instructions</h2>
      <ul>
      <li>Use the boxes to confirm each reporting item.</li>
      <li>Add reviewer notes under each section as needed.</li>
      </ul>
      <h2 id="administrative-information">Administrative
      information</h2>
      <ul class="task-list">
      <li><label><input type="checkbox" /><strong>1. Title:</strong>
      Descriptive title that identifies the study as a randomised trial,
      the interventions, the trial acronym, and the SPIRIT item this
      protocol is based on.</label></li>
      <li><label><input type="checkbox" /><strong>2. Trial
      registration:</strong> Trial identifier and registry name. If not
      yet registered, name of intended registry.</label></li>
      <li><label><input type="checkbox" /><strong>3. Protocol
      version:</strong> Date and version identifier.</label></li>
      <li><label><input type="checkbox" /><strong>4. Funding:</strong>
      Sources and types of financial, material, and other
      support.</label></li>
      <li><label><input type="checkbox" /><strong>5. Roles and
      responsibilities:</strong> Names, affiliations, and roles of
      protocol contributors.</label></li>
      </ul>
      <h2 id="introduction">Introduction</h2>
      <ul class="task-list">
      <li><label><input type="checkbox" /><strong>6. Background and
      rationale:</strong> Description of research question and
      justification for undertaking the trial, including summary of
      relevant studies.</label></li>
      <li><label><input type="checkbox" /><strong>7.
      Objectives:</strong> Specific objectives or
      hypotheses.</label></li>
      </ul>
      <h2 id="methods-participants-interventions-and-outcomes">Methods:
      Participants, interventions, and outcomes</h2>
      <ul class="task-list">
      <li><label><input type="checkbox" /><strong>8. Trial
      design:</strong> Description of trial design including type of
      trial, allocation ratio, and framework.</label></li>
      <li><label><input type="checkbox" /><strong>9. Study
      setting:</strong> Description of study settings.</label></li>
      <li><label><input type="checkbox" /><strong>10. Eligibility
      criteria:</strong> Inclusion and exclusion criteria for
      participants.</label></li>
      <li><label><input type="checkbox" /><strong>11.
      Interventions:</strong> Interventions for each group with
      sufficient detail to allow replication.</label></li>
      <li><label><input type="checkbox" /><strong>12. Outcomes:</strong>
      Primary, secondary, and other outcomes.</label></li>
      </ul>
      <h2
      id="methods-assignment-of-interventions-for-controlled-trials">Methods:
      Assignment of interventions (for controlled trials)</h2>
      <ul class="task-list">
      <li><label><input type="checkbox" /><strong>13.
      Allocation:</strong> Sequence generation, concealment mechanism,
      and implementation.</label></li>
      <li><label><input type="checkbox" /><strong>14. Blinding
      (masking):</strong> Who will be blinded and how.</label></li>
      </ul>
      <h2 id="methods-data-collection-management-and-analysis">Methods:
      Data collection, management, and analysis</h2>
      <ul class="task-list">
      <li><label><input type="checkbox" /><strong>15. Data collection
      methods:</strong> Plans for assessment and collection of outcome,
      baseline, and other trial data.</label></li>
      <li><label><input type="checkbox" /><strong>16. Data
      management:</strong> Plans for data entry, coding, security, and
      storage.</label></li>
      <li><label><input type="checkbox" /><strong>17. Statistical
      methods:</strong> Statistical methods for analysing primary and
      secondary outcomes.</label></li>
      </ul>
      <h2 id="methods-monitoring">Methods: Monitoring</h2>
      <ul class="task-list">
      <li><label><input type="checkbox" /><strong>18. Data
      monitoring:</strong> Plans for data monitoring.</label></li>
      <li><label><input type="checkbox" /><strong>19. Harms:</strong>
      Plans for collecting, assessing, reporting, and managing solicited
      and spontaneously reported adverse events and other unintended
      effects of trial interventions or trial conduct.</label></li>
      <li><label><input type="checkbox" /><strong>20. Auditing:</strong>
      Frequency and procedures for auditing trial conduct.</label></li>
      </ul>
      <h2 id="ethics-and-dissemination">Ethics and dissemination</h2>
      <ul class="task-list">
      <li><label><input type="checkbox" /><strong>21. Research ethics
      approval:</strong> Plans for seeking research ethics
      committee/institutional review board approval.</label></li>
      <li><label><input type="checkbox" /><strong>22. Protocol
      amendments:</strong> Plans for communicating important protocol
      modifications to relevant parties.</label></li>
      <li><label><input type="checkbox" /><strong>23. Consent or
      assent:</strong> Who will obtain informed consent or assent from
      potential trial participants or authorized surrogates, and
      how.</label></li>
      <li><label><input type="checkbox" /><strong>24.
      Confidentiality:</strong> How personal information about potential
      and enrolled participants will be collected, shared, and
      maintained in order to protect confidentiality before, during, and
      after the trial.</label></li>
      <li><label><input type="checkbox" /><strong>25. Declaration of
      interests:</strong> Financial and other competing interests for
      principal investigators for the overall trial and each study
      site.</label></li>
      <li><label><input type="checkbox" /><strong>26. Access to
      data:</strong> Statement of who will have access to the final
      trial dataset, and disclosure of contractual agreements that limit
      such access for investigators.</label></li>
      <li><label><input type="checkbox" /><strong>27. Ancillary and
      post-trial care:</strong> Provisions, if any, for ancillary and
      post-trial care, and for compensation to those who suffer harm
      from trial participation.</label></li>
      <li><label><input type="checkbox" /><strong>28. Dissemination
      policy:</strong> Plans for investigators and sponsors to authors
      and other stakeholders to share trial results.</label></li>
      <li><label><input type="checkbox" /><strong>29. Authorship
      eligibility:</strong> Guidelines for authorship eligibility for
      trial publications.</label></li>
      <li><label><input type="checkbox" /><strong>30.
      Reproducibility:</strong> Plans for sharing of original data and
      statistical code.</label></li>
      </ul>
      <h2 id="appendices">Appendices</h2>
      <ul class="task-list">
      <li><label><input type="checkbox" /><strong>31. Informed consent
      materials:</strong> Model consent form and other related
      documentation given to participants and authorized
      surrogates.</label></li>
      <li><label><input type="checkbox" /><strong>32. Biological
      specimens:</strong> Plans for collection, laboratory evaluation,
      and storage of biological specimens for genetic or molecular
      analysis in the current trial and for future use in ancillary
      studies, if applicable.</label></li>
      </ul>
      <p><span class="textfield" name="spirit_2025_notes"
      width="12cm">Notes</span></p>
      <h2 id="provenance">Provenance</h2>
      <ul>
      <li>Source: See sidecar metadata in
      <code>source/archetypes/spirit-2025.yml</code></li>
      <li>Version: 2025</li>
      <li>License: CC-BY-4.0</li>
      </ul>
    </main>

    <footer class="pt-3 mt-4 text-muted border-top">
      Generated by the standards_check project.
    </footer>
  </div>

  <script src="/assets/js/app.js"></script>
  <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.3/dist/js/bootstrap.bundle.min.js"></script>
</body>
</html>
